Article By:
NASDAQ GlobeNewswire
Tuesday, January 16, 2018 10:31 PM EDT
HTG Molecular Diagnostics, Inc. today announced that it intends to offer and sell, subject to market and other conditions, 10,000,000 shares of its common stock in an underwritten public offering.
In this article: HTGM
